{"raw_mentions": "There are no sentences that meet the specified criteria. The text snippet provided does not contain any sentences with a specific molecule name, ID, or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50, etc.), a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n(7\u03b1,16\u03b2,17\u03b1)-3,17-dihydroxy-7-propyl-16,24-cyclo-19,21-dinorchola-1,3,5(10)-trien-22-one (Compound 10) is unique in having a combined partial ER/partial PR (ant)agonistic profile with an EC50 of 1.8 nmol/L for ER\u03b1 and of 3.8 nmol/L for progesterone receptor B (PR-B).\n(7\u03b1,16\u03b2,17\u03b1)-3,17-dihydroxy-7-propyl-16,24-cyclo-19,21-dinorchola-1,3,5(10)-trien-22-one is an antagonist for the androgen receptor (AR) with an IC50 of 125 nM.\nER\u03b1 ago EC50; eff1.8 nM; 0.63\nER\u03b1 ant IC50; anteff10.0 nM; 0.47\nER\u03b2 ago EC50; eff>10,000 nM\nER\u03b2 ant IC50; anteff8.4 nM; 0.83\nPR-B ago EC50; eff3.8 nM; 0.49\nPR-B ant IC50; anteff3.7 nM; 0.55\nPR-A ago EC50; eff30.0 nM; 0.46\nPR-A ant IC50; anteff27.0 nM; 0.54\nIn a 4-week phase I study, female human volunteers were exposed to the compound (7\u03b1,16\u03b2,17\u03b1)-3,17-dihydroxy-7-propyl-16,24-cyclo-19,21-dinorchola-1,3,5(10)-trien-22-one (Compound 10) at blood plasma level with Cmax of 16 nM, endometrial biopsies were obtained on day 29. \nThe minimal active dose (MAD) for ovulation inhibition upon oral dosing in gelatine/mannitol was established at <=0.1 mg/kg per day."}
{"final_json": [{"molecule_name": "Compound 10", "protein_target_name": "ER\u03b1", "binding_metric": "EC50", "value": "1.8", "unit": "nmol/L"}, {"molecule_name": "Compound 10", "protein_target_name": "PR-B", "binding_metric": "EC50", "value": "3.8", "unit": "nmol/L"}, {"molecule_name": "Compound 10", "protein_target_name": "AR", "binding_metric": "IC50", "value": "125", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "ER\u03b1", "binding_metric": "EC50", "value": "1.8", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "ER\u03b1", "binding_metric": "IC50", "value": "10.0", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "ER\u03b2", "binding_metric": "EC50", "value": ">10,000", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "ER\u03b2", "binding_metric": "IC50", "value": "8.4", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "PR-B", "binding_metric": "EC50", "value": "3.8", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "PR-B", "binding_metric": "IC50", "value": "3.7", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "PR-A", "binding_metric": "EC50", "value": "30.0", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "PR-A", "binding_metric": "IC50", "value": "27.0", "unit": "nM"}, {"molecule_name": "Compound 10", "protein_target_name": null, "binding_metric": "Cmax", "value": "16", "unit": "nM"}, {"molecule_name": "Compound 10", "protein_target_name": null, "binding_metric": null, "value": "<=0.1", "unit": "mg/kg per day"}]}
